Advertisement

Topics

Lexicon Pharmaceuticals, Inc. Company Profile

13:07 EDT 23rd March 2019 | BioPortfolio

Lexicon is a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease. Lexicon currently has four drug candidates in mid-stage development for diabetes, irritable bowel syndrome, carcinoid syndrome and rheumatoid arthritis, all of which were discovered by Lexicon's research team. Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets. Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs. For additional information about Lexicon and its programs, please visit www.lexpharma.com.


News Articles [436 Associated News Articles listed on BioPortfolio]

Lexicon Pharmaceuticals: from Discovery to Development

In this exclusive interview, Fintan Walton talks to Arthur Sands, President and Chief Executive Officer of Lexicon Pharmaceuticals, about the company's recent name change from Lexicon Genetics and how...

Lexicon Pharmaceuticals Announces Dosing of First Patient in TELE-ABC Study

Lexicon Pharmaceuticals (NASDAQ:LXRX) has announced the dosing of the first patient in the Telotristat Ethyl for Advanced Biliary Tract Cancer (TELE-ABC) in a Phase2a clinical study of telotristat eth...

Lexicon doses first patient in biliary tract cancer drug study

The first patient has been dosed in a Phase IIa study for Lexicon Pharmaceuticals' Xermelo, or telotristat ethyl, for the tre -More- 

FDA Advisory Panel Splits Vote On Sanofi-Lexicon Diabetes Drug

PARIS (dpa-AFX) - Lexicon Pharmaceuticals, Inc. (LXRX) said that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration voted eight to eight on the ques...

Lexicon/Sanofi’s Zynquista divides experts on FDA approval prospects in T1D

Lexicon Pharmaceuticals and Sanofi’s Zynquista (sotagliflozin) has split expert views on whether it will attain FDA approval as an adjunct therapy to insulin...Read More... The post Lexicon/Sanof...

FDA panel split on Sanofi-Lexicon diabetes drug

A U.S. FDA advisory panel to the voted 8-8 over whether to recommend approval of a treatment for type 1 diabetes developed by Sanofi and Lexicon Pharmaceuticals.

Sanofi-Lexicon diabetes drug gets split verdict from FDA panel

Sanofi and Lexicon Pharmaceuticals have received split decision from an advisory panel to the US Food and Drug Administration (FDA)...Read More... The post Sanofi-Lexicon diabetes drug gets split verd...

FDA rejects Sanofi-Lexicon add-on pill for type 1 diabetes

The U.S. Food and Drug Administration declined to approve a drug developed by Sanofi SA and Lexicon Pharmaceuticals Inc intended for use with insulin in patients with type 1 diabetes, the companies sa...

Drugs and Medications [0 Results]

None

PubMed Articles [162 Associated PubMed Articles listed on BioPortfolio]

Improving the performance of lexicon-based review sentiment analysis method by reducing additional introduced sentiment bias.

Sentiment analysis is widely studied to extract opinions from user generated content (UGC), and various methods have been proposed in recent literature. However, these methods are likely to introduce ...

Swimming activity in zebrafish larvae exposed to veterinary antiparasitic pharmaceuticals.

Veterinary antiparasitic pharmaceuticals have been detected in surface waters and several of these pharmaceuticals act on the nervous system on the target organisms implying that neurological effects ...

Insight into the distribution of pharmaceuticals in soil-water-plant systems.

Pharmaceuticals in agricultural soils originating from irrigation with treated wastewater and land-applied biosolids can enter field crops. However, little is known about the role of pore water in pla...

U.S. Emergency Department Visits Resulting From Nonmedical Use of Pharmaceuticals, 2016.

National data on morbidity from nonmedical use of pharmaceuticals are limited. This study used nationally representative, public health surveillance data to characterize U.S. emergency department visi...

Chiral pharmaceuticals: Environment sources, potential human health impacts, remediation technologies and future perspective.

Chiral pharmaceuticals (CPs), including non-steroid anti-inflammatory drugs (NSAIDs), β-blockers and some herbicide and pesticides, are widely used in aquaculture, clinical treatment and many other f...

Clinical Trials [232 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1359 Associated Companies listed on BioPortfolio]

Lexicon Pharmaceuticals, Inc.

Lexicon is a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease. Lexicon currently has four drug candidates in mid-stage development for diabete...

Lexicon Pharmaceuticals

Lexicon Genetics is focused on the discovery and development of breakthrough treatments for human disease. We use our proprietary gene knockout technology to systematically discover the physiological ...

Pharma-Lexicon International

Pharma-Lexicon International is based in Cancun, Mexico. We also have an office in East Sussex in the United Kingdom. MediLexicon has the world's largest online database of pharmaceutical and medical ...

NIKE WORLD

Bill Bowerman said this a couple of decades ago. The guy was right. It defines how he viewed the world, and it defines how Nike pursues its destiny. Ours is a language of sports, a universally underst...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

More Information about "Lexicon Pharmaceuticals, Inc." on BioPortfolio

We have published hundreds of Lexicon Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Lexicon Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Lexicon Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lexicon Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Lexicon Pharmaceuticals, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record